Annals of neurology

Clinical trials: rising costs limit innovation.

Annals of neurology

Johnston SC, Hauser SL

Epilepsy genetics: yet more exciting news.

Annals of neurology

Lowenstein D, Messing R

Pharmacoresistant epilepsy: if at first you don't succeed...

Annals of neurology

Shih T, Lowenstein D

The upcoming meeting of the ANA.

Annals of neurology

Hauser SL, Johnston SC

Matriculating the next generation of clinician-scientists.

Annals of neurology

Hauser SL, Johnston SC

Early editorial manuscript screening versus obligate peer review: a randomized trial.

Annals of neurology

Johnston SC, Lowenstein DH, Ferriero DM, Messing RO, Oksenberg JR, Hauser SL

Of ghosts and sirens: the subtlest lures of industry.

Annals of neurology

Hauser SL, Johnston SC

A second major histocompatibility complex susceptibility locus for multiple sclerosis.

Annals of neurology

Yeo TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, Goris A, Fenoglio C, Ban M, Taylor CJ, Goodman RS, Walsh E, Wolfish CS, Horton R, Traherne J, Beck S, Trowsdale J, Caillier SJ, Ivinson AJ, Green T, Pobywajlo S, Lander ES, Pericak-Vance MA, Haines JL, Daly MJ, Oksenberg JR, Hauser SL, Compston A, Hafler DA, Rioux JD, Sawcer S

Marketing and drug costs: who is laughing and crying?

Annals of neurology

Johnston SC, Hauser SL

Pages